Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;5(1):43-9.
doi: 10.4103/0975-9476.128857.

Immunophenotyping of normal individuals classified on the basis of human dosha prakriti

Affiliations

Immunophenotyping of normal individuals classified on the basis of human dosha prakriti

Harish Rotti et al. J Ayurveda Integr Med. 2014 Jan.

Abstract

Background: Human variations related to immune response and disease susceptibility is well-documented in Ayurveda. Prakriti (body constitution) is the basic constitution of an individual established at the time of birth and distinguishes variations, into three broad phenotype categories such as vata, pitta and kapha. Variation in immune response is often attributed to and measured from the difference in cluster differentiation (CD) markers expressed in lymphocytes. Currently, there are no reports available on the expression of CD markers related to prakriti.

Objective: This is a pilot study performed to evaluate a panel of lymphocyte subset CD markers in dominant prakriti individuals.

Materials and methods: Immunophenotyping was carried out using whole blood from a total of healthy 222 subjects, who are grouped into kapha (n = 95), pitta (n = 57) and vata (n = 70) prakritis. CD markers such as CD3, CD4, CD8, CD14, CD25, CD56, CD69, CD71 and HLA-DR were analyzed using flow cytometry method. Differences between groups were analyzed using one-way ANOVA or Kruskal-Wallis analysis of variance (ANOVA) and multiple comparisons between groups were performed by Bonferroni or Mann-Whitney U test with corrections for type I error respectively. Significance was evaluated by ANOVA and Pearson's correlation.

Results: We observed a significant difference (P < 0.05) in the expression of CD markers such as CD14 (monocytes), CD25 (activated B cells) and CD56 (Natural killer cells) between different prakriti groups. CD25 and CD56 expression was significantly higher in kapha prakriti samples than other prakriti groups. Similarly, slightly higher levels of CD14 were observed in pitta prakriti samples.

Conclusion: Significant difference in the expression of CD14, CD25 and CD56 markers between three different prakriti is demonstrated. The increased level of CD25 and CD56 in kapha prakriti may indicate ability to elicit better immune response, which is in conformity with textual references in Ayurveda.

Keywords: Cluster differentiation 14; cluster differentiation 25; cluster differentiation 56; immunophenotyping; prakriti.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Expression of significant cluster differentiation markers across three prakriti. Scatter plot for expression of CD14, CD25 and CD56 which are significant in expression between three dominant prakriti (P < 0.05). Significance with the highest mean value was represented in * sign
Figure 2
Figure 2
Pearson correlation matrix to find correlation between percentage of prakriti and cluster differentiation 14, CD25 and CD56 expression. Data represented as the percentage values of kapha, pitta and vata obtained from the Ayusoft against, the absolute count of CD marker of the population studied. The values inside the boxes are the Pearson's correlation r values and statistical significance is represented by * sign

Similar articles

Cited by

References

    1. Banerjee M. Is pharmacogenomics a reality? Challenges and oppurtunities for India. Indian J Hum Genet. 2011;17(Suppl 1):S1–3. - PMC - PubMed
    1. Ginsburg GS, Willard HF. Genomic and personalized medicine: Foundations and applications. Transl Res. 2009;154:277–87. - PubMed
    1. Hankey A. The scientific value of Ayurveda. J Altern Complement Med. 2005;11:221–5. - PubMed
    1. Jayasundar R. Ayurveda: A distinctive approach to health and disease. Curr Sci. 2010;98:908–14.
    1. Valiathan MS. Chennai: Orient Longman; 2003. The Legacy of Caraka.

LinkOut - more resources